海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
195件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- Study Evaluating the Efficacy and Safety of Bapineuzumab in Alzheimer Disease Patients Who Are Apolipoprotein E e4 Carriers
- Alzheimer Disease MedDRA version: 14.1 Level: PT Classification code 10012271 Term: Dementia Alzheimer's type System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Australia, Austria, Belgium, Chile, Croatia, Denmark, Finland, France, Germany, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Poland, Portugal, Serbia, Slovakia, South Africa, Spain, Sweden, Switzerland, United Kingdom, United States
- 2008-02-22
Not Recruiting
- Ensayo de fase III, multicéntrico, aleatorizado, en doble ciego, controlado con placebo y de grupos paralelos, sobre la eficacia y la seguridad del bapineuzumab (AAB-001, ELN115727) en pacientes con enfermedad de Alzheimer de grado leve a moderado que no son portadores de la apolipoproteína E (ApoE) e4 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E e4 Non-carriers
- Enfermedad de Alzheimer Alzheimer Disease MedDRA version: 9.1 Level: PT Classification code 10012271 Term: Dementia Alzheimer's type ;Enfermedad de Alzheimer Alzheimer Disease MedDRA version: 9.1 Level: PT Classification code 10012271 Term: Dementia Alzheimer's type
- Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Portugal, Slovakia, Spain, Sweden, United Kingdom
- 2008-02-25
Not Recruiting
- A 54-week, double-blind, randomized, placebo-controlled, parallel-group study to investigate the effects of rosiglitazone (extended release tablets) as adjunctive therapy to donepezil on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease (REFLECT-2) - REFLECT-2
- Alzheimers Disease MedDRA version: 8.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease ;Alzheimers Disease MedDRA version: 8.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease
- Austria, Czech Republic, Germany, Greece, Hungary, Italy, Portugal, Spain
- 2006-07-20
Not recruiting
- Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
- Alzheimer's Disease
- Austria, Canada, Germany, United States
- 2007-12-10
Not recruiting
- Anti-inflammatory and antimicrobial effects of nicotinamide in bronchiectasis
- non-cystic fibrosis bronchiectasis
- ,Outside, New Zealand
- 2015-04-20
Not recruiting
- Effect of Breathing a Mixture of 92% Oxygen (O2) + 8% Carbon Dioxide (CO2) on Flicker Induced Blood Flow Changes in Ocular Perfusion
- Flicker-induced Vasodilatation
- Austria
- 2008-07-01
Not Recruiting
- Efficacy and tolerability of nicotinamide as add-on therapy compared to placebo in dialysis-dependent patients with elevated phosphat level
- Dialysis-dependent patients with hyperphosphatemia MedDRA version: 19.0 Level: LLT Classification code 10020712 Term: Hyperphosphatemia System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Austria, Germany, Hungary, Poland
- 2013-07-04
Not recruiting
- Nicotinamide and innate immunity in patients with bronchiectasis
- Bronchiectasis
- ,Outside, New Zealand
- 2013-06-26
Not Recruiting
- A Clinical Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical MonoPointTM Reperfusion SystemTM for Aspiration Embolectomy in Acute Ischemic Stroke Patients
- Acute Ischemic Stroke; Acute Ischemic Stroke;Stroke - Ischaemic;Neurological - Other neurological disorders
- New Zealand
- 2019-06-26
Not recruiting
- The effects of kiwifruit on markers of cardiovascular health in men with high cholesterol levels.
- Dyslipidemia;Metabolic factors associated with cardiovascular risk;ApoE genotype
- ,Outside, New Zealand
- 2010-03-16